FDA Inspection 1037745 — Lenox Hill Hospital
The FDA completed an inspection of Lenox Hill Hospital on December 14, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)